Look for:

Our offer for

ORION CORPORATION B


ISIN:
FI0009014377
WKN:
ORNBV

2022/11/28 17:29:31
Price
49.79 EUR
Difference 1.65% (0.81)

General attributes

ISINFI0009014377
SymbolORNBV
ExchangeNasdaq Helsinki
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)5,287 EUR
BenchmarkOMX HELSINKI 25

Market data

Bid (Bid size)49.73 EUR (45)
Ask (Ask size)49.77 EUR (120)
Open48.92 EUR
High49.82 EUR
Low48.90 EUR
Close (prev. day)48.98 EUR
VWAP49.634805 EUR
Volume (pcs)175,129
Trading volume8,692,329.08
Number of trades2,442
Last size119

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: ORION CORPORATION BPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/11/28 17:29:31
Price
49.79 EUR
Difference 1.65% (0.81)

General attributes

ISINFI0009014377
SymbolORNBV
ExchangeNasdaq Helsinki
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)5,287 EUR
BenchmarkOMX HELSINKI 25

Market data

Bid (Bid size)49.73 EUR (45)
Ask (Ask size)49.77 EUR (120)
Open48.92 EUR
High49.82 EUR
Low48.90 EUR
Close (prev. day)48.98 EUR
VWAP49.634805 EUR
Volume (pcs)175,129
Trading volume8,692,329.08
Number of trades2,442
Last size119

Performance and Risk

6m1Y3Y
Perf (%)+31.86%+34.79%+26.31%
Perf (abs.)+12.03+12.85+10.37
Beta0.110.350.36
Volatility28.6034.8431.31
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)49.24 EUR (144,442)
Ø price 30 days | Ø volume 30 days (pcs.)46.65 EUR (252,855)
Ø price 100 days | Ø volume 100 days (pcs.)45.69 EUR (245,271)
Ø price 250 days | Ø volume 250 days (pcs.)41.24 EUR (314,825)
YTD High | date49.82 EUR (2022/11/28)
YTD Low | date33.75 EUR (2022/05/02)
52 Weeks High | date49.82 EUR (2022/11/28)
52 Weeks Low | date33.75 EUR (2022/05/02)

All listings for ORION CORPORATION B

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2022/11/2522:0249.02 EUR0.001
Stuttgart2022/11/2815:4049.62 EUR0.007
Nasdaq Helsinki2022/11/2817:2949.79 EUR8.692,442
Munich2022/11/2808:0348.90 EUR0.001
London Stock Exchange European Trade Reporting2022/11/2817:2549.60 EUR0.002
Frankfurt2022/11/2809:4249.19 EUR0.001
FINRA other OTC Issues2022/02/0817:4340.2946 USD0.101
Duesseldorf2022/11/2818:3149.72 EUR0.0010
Berlin2022/11/2808:0348.81 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=450&ID_TYPE_IMAGE_LOGO=2

Contact Details

ORION OYJ
- -
Orionintie 1A - 02200 Espoo
Telefon: 358-10-4261
Fax: -
E-mail: -

PDF Downloads

Company report: ORION CORPORATION BPDF Download

Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.

Members of Management Board

Timo LappalainenChairman of Managing Board
Jani KorhonenMember of Executive Committee
Jari KarlsonMember of Executive Committee
Liisa HurmeMember of Executive Committee
Olli HuotariMember of Executive Committee
Outi VaaralaMember of Executive Committee
Satu AhomäkiMember of Executive Committee
Virve LaitinenMember of Executive Committee

Board of directors

Erkki Mikael SilvennoinenChairman of Supervisory Board
Hilpi RautelinMember of Supervisory Board
Ari Tapio LehtorantaMember of Supervisory Board
Eija RonkainenMember of Supervisory Board
Karen SörensenMember of Supervisory Board
Kari Jussi AhoMember of Supervisory Board
Maziar Mike DoustdarMember of Supervisory Board
Veli-Matti Johannes MattilaMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer